Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Observational, Prospective Study of Molecular Profiling in Advanced and Aggressive Endometrial Cancer Patients and 1-st Line Treatment Approaches in Russian Federation

NCT07041606 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07041606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07041606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Observational, Prospective Study of Molecular Profiling in Advanced and Aggressive Endometrial Cancer Patients and 1-st Line Treatment Approaches in Russian Federation
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
June 24, 2025
Completion date
June 30, 2027
Enrollment
500 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer